Valeria Solozobova

A chemical probe for BAG1 targets androgen receptor-positive prostate cancer through oxidative stress signaling pathway

Myles A Brown, G. Nienhaus, K. Nienhaus, 2022, iScience.

Development of a Benzothiazole Scaffold-Based Androgen Receptor N-Terminal Inhibitor for Treating Androgen-Responsive Prostate Cancer.

A. Zoubeidi, Yu Chen, S. Bräse, 2021, ACS chemical biology.

Identification of an Imidazopyridine-based Compound as an Oral Selective Estrogen Receptor Degrader for Breast Cancer Therapy

C. Blattner, V. Orian-Rousseau, N. Jung, 2023, Cancer research communications.

TRIM25 targets p300 for degradation

W. Zwart, S. Elabd, Valeria Solozobova, 2023, Life Science Alliance.